Health Technology Innovations

HTI supplies AI enabled software tools and services for structure-based drug discovery (SBDD). Cryo-EM allows scientists to determine molecular structures at atomic resolution to better understand mechanisms of action and binding properties of proteins and complexes. HTI’s CryoDiscoveryTM software and patent pending CryoFAST™ data collection architecture uses deep learning to fully automate Cryo-EM data collection and processing workflow to improve the throughput, accuracy, and cost of structure determination. HTI also provides protein production and cryoem structure determination services.

AI-Enabled Services:

• Research services that use machine learning (ML) algorithms